The research conducted by Edith Cowan University has made a critical breakthrough in the treatment of non-small cell lung cancer.
The team examined the human leukocyte antigens (HLAs) of 179 non-small cell lung cancer patients and found a strong link between the genetic makeup of the HLAs and whether the patient was likely to develop side effects from immunotherapy.
This discovery could have major implications for treatment, as it will allow doctors to better tailor therapies to individual patients, potentially reducing side effects.
It could also mean that more people are able to benefit from immunotherapy, as it could be used more safely in those who are at higher risk of adverse reactions.
This discovery is a major step forward in the battle against this deadly form of cancer and could save countless lives.
Read more > Edith Cowen University
